Unravelling the molecular complexities of early-stage oestrogen receptor positive breast cancer to identify biomarkers of resistance to endocrine therapy 

Bergamino Sirvén, Milana Arantza (Date of defense: 2022-11-29)

[eng] 80% of breast cancer (BC) express positive estrogen receptors (ER+) and up to 15% of them also overexpress or amplify the human epidermal growth factor receptor 2 (HER2), which confers a molecular biology and different ...